Almotriptan Malate

苹果酸阿莫曲坦

Report date: 2023/03/22 14:21:40
NME

Base Information

Drug NameAlmotriptan Malate
Drug Alias Name苹果酸阿莫曲普坦almotriptanalmotriptanum阿莫曲坦Axert +[8
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin (5-HT) receptor agonists
TargetsSerotonin (5-HT) receptor
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsMigraine Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritorySpain
Original Approved Date1999/12/29
Country/TerritoryUnited StatesSpainMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesAlmirall Sa
China Registration ClassN/A

Develop Information

Active CompaniesAlmirall Sa
Active IndicationsMigraine Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN02CC05